Skip to content

Effectiveness of Local Application of Magnesium Sulphate drug via a Therapeutic Electronic Device (Iontophoresis) on Pain, Tenderness and Shoulder Disability in Athletes with Painful Localised Points (Trigger points) around Shoulder Blade (Scapula).

Efficacy Of Magnesium Sulphate Iontophoresis On Pain, Tenderness And Functional Independence of Shoulder In Athletes With Trigger Points Around Scapula

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/02/049576
Enrollment
216
Registered
2023-02-09
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M758- Other shoulder lesions

Interventions

Intervention1: Magnesium Sulphate Iontophoresis: Iontophoresis is a non invasive technique in which an ionized form of drug is being used to deliver the medicine through electrotherapeutic modality. T

Sponsors

Mohit Gulati
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Athletes who practise weight lifting as a part of training. 2. Athletes participating in sports for more than 3 years. 3. Both male and female athletes. 4. Age 15 – 30 years. 5. Pain present in shoulder movement. 6. Presence of Trigger points around Scapula evaluated by another medical practitioner, found by pincer palpation in high sitting position. 7. Trigger Points which is present for more than 1 month. 8. Only 2 most painful trigger points will be chosen around the scapula which is more tender according to Pain Pressure Threshold readings.

Exclusion criteria

Exclusion criteria: 1. Any previous injury to Scapulae, Clavicle and shoulder joint like fracture, muscle or other soft tissue tears in the last 6 months. 2. Recent history of surgery around scapulae, shoulder joint complex or spine within 6 months. 3. Any diseased conditions which are contraindicated for Physiotherapy. 4. Athlete who is participating in a competition within two months. 5. Similar musculoskeletal conditions such as Fibromyalgia, Delayed Onset Muscle Soreness (DOMS).

Design outcomes

Primary

MeasureTime frame
The research will assess for : 1. PAIN - Measured by NPRS 2. Tenderness - Measured by Pain Pressure Threshold 3. Functional Independence - Measured by Shoulder Pain and Disability Index (SPADI) Timepoint: Intervention twice weekly for 4 weeks. Follow up after one month. Total 60 days.

Secondary

MeasureTime frame
Pain, Tenderness and Shoulder disability.Timepoint: After one month

Countries

India

Contacts

Public ContactMohit Gulati

Chitakara University, Punjab

navita.gupta@chitkara.edu.in

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026